
BioPharma Solutions
Miss our Lipid Management Drugs in Development webinar?
Watch recording
Free Intelligence
BioPharm Insight is pleased to provide you with select recent articles as examples of the forward-looking intelligence that our clients use to gain an information edge over their peers. If you like what you see, get a free trial below for full access.
Most Read Articles - Week of May 14, 2012
- Celldex open to partnering with CRO to run 400- to 500-patient Phase III breast cancer trial, CMO says
- Teva's Phase I/II pain drug study faces patient recruitment delays, enrollment criteria at fault - investigators
- Biosimilar developers of RA drugs likely to enroll many patients in pharmacovigilance studies, EMA official says
- Increasing number of CROs actively approaching pharma for investment opportunities - analysis
- Medivation's prostate cancer drug MDV3100 seizure risk unlikely to affect approval - oncologists
